Vonoprazan

Vonoprazan es un fármaco en desarrollo de Phathom Pharmaceuticals. Tiene 14 ensayos clínicos registrados, 3 en marcha; lo más avanzado, no aplica.

PHAT Phathom Pharmaceuticals

Sus ensayos

Para qué	Fase	Estado
A Study in Adult Participants With EoE to Evaluate Vonoprazan 20 mg Compared to Placebo After 12 Weeks and to Evaluate Vonoprazan 20 mg Up to 24 Weeks NCT06851559	Fase 2	En marcha, sin reclutar
A Study to Evaluate the Efficacy and Safety of Vonoprazan 10 mg Compared to Placebo for Relief of Episodic Heartburn in Participants With Symptomatic Non-Erosive Gastroesophageal Reflux Disease Through 24 Weeks NCT07752407	Fase 3	Reclutando pacientes
A Study of the Safety of Vonoprazan Exposure in Pregnant Women and Their Offspring NCT06660342	no aplica	Reclutando pacientes
A Study to Evaluate Vonoprazan Concentrations in Breast Milk of Healthy Lactating Women Receiving Vonoprazan 20 mg Once Daily or Vonoprazan 20 mg Twice Daily NCT06391177	Fase 1	Completado
A Study to Evaluate Vonoprazan in Children Who Have Symptomatic Gastroesophageal Reflux Disease NCT06106022	Fase 1	Completado
A Study to Evaluate the Pharmacokinetics, Pharmacodynamics and Safety of Vonoprazan in Adolescents With Symptomatic Gastroesophageal Reflux Disease NCT05343364	Fase 1	Completado
A Study to Evaluate the Efficacy and Safety of Vonoprazan Compared to Placebo for Relief of Heartburn in Participants With Symptomatic Non-Erosive Gastroesophageal Reflux Disease (NERD) NCT05195528	Fase 3	Completado
A Study to Determine the Bioavailability of Vonoprazan Sprinkle Capsules on Pudding or on Applesauce Relative to a Vonoprazan Tablet in Healthy Participants NCT05366738	Fase 1	Completado
A Study to Evaluate the Efficacy and Safety of Vonoprazan Compared to Placebo in Participants With Symptomatic Non-Erosive Gastroesophageal Reflux Disease NCT04799158	Fase 2	Completado
Efficacy and Safety of Vonoprazan Compared to Lansoprazole in Participants With Erosive Esophagitis NCT04124926	Fase 3	Completado
Study to Evaluate the Pharmacokinetics, Pharmacodynamics, and Safety of Vonoprazan and Lansoprazole in Healthy Participants NCT04729101	Fase 1	Completado
Efficacy and Safety of Vonoprazan Compared to Lansoprazole in Participants With Helicobacter Pylori Infection NCT04167670	Fase 3	Completado
Evaluation of Effect of Rifampin on the Pharmacokinetics of Vonoprazan in Healthy Participants NCT04558216	Fase 1	Retirado antes de empezar
Evaluation of Effect of Vonoprazan on Midazolam Pharmacokinetics in Healthy Participants NCT04545944	Fase 1	Completado

¿Cuándo se esperan resultados? Está en el calendario, para quien tiene cuenta. Crear una cuenta.

Ensayos del registro público de ClinicalTrials.gov; noticias, de los documentos que la empresa presenta ante la SEC. No son recomendaciones de inversión.